feed,title,long_url,short_url
SeekingAlpha,AbbVie hits main goal in Phase 2 trial for Rinvoq in vitiligo,https://seekingalpha.com/news/4020009,
SeekingAlpha,Rithm Capital boosts price for Sculptor Capital to $12 per share,https://seekingalpha.com/news/4020002,
